Sangamo Therapeutics IncNASDAQ:SGMONASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)
- LAST PRICE0.5828
- TODAY'S CHANGE (%)0.0184 (3.2601%)
- Bid / Lots0.5693/ 11
- Ask / Lots0.6080/ 10
- Open / Previous Close0.5610 / 0.5644
- Day Range
- 52 Week Range
- Volume1,306,394
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | SGMO |
|---|---|---|
| 09:32 ET | 11973 | 0.569 |
| 09:34 ET | 5475 | 0.562625 |
| 09:36 ET | 3016 | 0.5612 |
| 09:38 ET | 16360 | 0.565 |
| 09:39 ET | 500 | 0.5699 |
| 09:43 ET | 7446 | 0.56 |
| 09:48 ET | 3333 | 0.5657 |
| 09:50 ET | 14533 | 0.562446 |
| 09:52 ET | 200 | 0.5623 |
| 09:54 ET | 1987 | 0.5602 |
| 09:56 ET | 921 | 0.5602 |
| 09:57 ET | 1992 | 0.5602 |
| 09:59 ET | 1525 | 0.5602 |
| 10:01 ET | 1130 | 0.5686 |
| 10:03 ET | 4367 | 0.5684 |
| 10:06 ET | 3030 | 0.5682 |
| 10:08 ET | 700 | 0.5691 |
| 10:10 ET | 2465 | 0.5726 |
| 10:12 ET | 88077 | 0.5746 |
| 10:14 ET | 200 | 0.5699 |
| 10:15 ET | 14350 | 0.5728 |
| 10:17 ET | 954 | 0.5791 |
| 10:19 ET | 13956 | 0.5747 |
| 10:21 ET | 5866 | 0.579 |
| 10:24 ET | 3832 | 0.5771 |
| 10:26 ET | 2612 | 0.5747 |
| 10:28 ET | 200 | 0.57735 |
| 10:30 ET | 820 | 0.5749 |
| 10:32 ET | 5123 | 0.5769 |
| 10:33 ET | 9255 | 0.5749 |
| 10:35 ET | 22771 | 0.57915 |
| 10:37 ET | 6745 | 0.579149 |
| 10:42 ET | 2300 | 0.5791 |
| 10:44 ET | 1025 | 0.58095 |
| 10:46 ET | 25207 | 0.575 |
| 10:48 ET | 8444 | 0.575301 |
| 10:50 ET | 200 | 0.5752 |
| 10:53 ET | 1381 | 0.5747 |
| 10:55 ET | 143 | 0.57735 |
| 11:00 ET | 339 | 0.5771 |
| 11:02 ET | 108 | 0.5767 |
| 11:04 ET | 600 | 0.5767 |
| 11:06 ET | 200 | 0.5752 |
| 11:08 ET | 359 | 0.5747 |
| 11:11 ET | 855 | 0.5742 |
| 11:13 ET | 1640 | 0.5742 |
| 11:15 ET | 210 | 0.577499 |
| 11:18 ET | 200 | 0.5742 |
| 11:20 ET | 924 | 0.5742 |
| 11:22 ET | 4575 | 0.57727 |
| 11:24 ET | 400 | 0.5727 |
| 11:26 ET | 2484 | 0.5757 |
| 11:27 ET | 700 | 0.5757 |
| 11:29 ET | 300 | 0.5735 |
| 11:31 ET | 100 | 0.5749 |
| 11:33 ET | 500 | 0.5735 |
| 11:38 ET | 200 | 0.5735 |
| 11:40 ET | 1300 | 0.5735 |
| 11:42 ET | 1032 | 0.57435 |
| 11:44 ET | 2497 | 0.57365 |
| 11:45 ET | 3622 | 0.56985 |
| 11:47 ET | 638 | 0.5697 |
| 11:49 ET | 100 | 0.5697 |
| 11:51 ET | 1358 | 0.565 |
| 11:54 ET | 200 | 0.5697 |
| 11:56 ET | 310 | 0.565 |
| 11:58 ET | 1360 | 0.565 |
| 12:00 ET | 2500 | 0.56675 |
| 12:02 ET | 5573 | 0.572 |
| 12:03 ET | 400 | 0.5701 |
| 12:05 ET | 106308 | 0.5733 |
| 12:07 ET | 1740 | 0.5762 |
| 12:09 ET | 800 | 0.5828 |
| 12:12 ET | 3200 | 0.5782 |
| 12:14 ET | 7800 | 0.583 |
| 12:16 ET | 4070 | 0.5825 |
| 12:18 ET | 31971 | 0.5851 |
| 12:20 ET | 75602 | 0.565 |
| 12:21 ET | 3215 | 0.5822 |
| 12:23 ET | 100 | 0.57165 |
| 12:25 ET | 1304 | 0.5822 |
| 12:27 ET | 400 | 0.58 |
| 12:30 ET | 200 | 0.57055 |
| 12:32 ET | 9835 | 0.579 |
| 12:34 ET | 300 | 0.5759 |
| 12:36 ET | 500 | 0.5789 |
| 12:38 ET | 942 | 0.5789 |
| 12:39 ET | 545 | 0.579 |
| 12:41 ET | 530 | 0.5759 |
| 12:43 ET | 300 | 0.5759 |
| 12:48 ET | 100 | 0.5759 |
| 12:50 ET | 100 | 0.5741 |
| 12:52 ET | 694 | 0.5729 |
| 12:54 ET | 6906 | 0.5729 |
| 12:57 ET | 1158 | 0.570749 |
| 01:01 ET | 400 | 0.5688 |
| 01:03 ET | 1500 | 0.57075 |
| 01:06 ET | 270 | 0.5688 |
| 01:08 ET | 200 | 0.568 |
| 01:10 ET | 490 | 0.568 |
| 01:12 ET | 3400 | 0.5643 |
| 01:14 ET | 700 | 0.5643 |
| 01:15 ET | 1090 | 0.5656 |
| 01:17 ET | 100 | 0.5656 |
| 01:19 ET | 318 | 0.5644 |
| 01:21 ET | 877 | 0.5643 |
| 01:24 ET | 200 | 0.5656 |
| 01:26 ET | 400 | 0.5643 |
| 01:28 ET | 100 | 0.5643 |
| 01:30 ET | 440 | 0.5643 |
| 01:32 ET | 100 | 0.5656 |
| 01:33 ET | 440 | 0.5643 |
| 01:35 ET | 32870 | 0.571 |
| 01:37 ET | 3842 | 0.5733 |
| 01:39 ET | 600 | 0.57325 |
| 01:42 ET | 540 | 0.57325 |
| 01:44 ET | 1143 | 0.5754 |
| 01:46 ET | 20492 | 0.5743 |
| 01:48 ET | 400 | 0.57455 |
| 01:50 ET | 1300 | 0.5738 |
| 01:51 ET | 100 | 0.5723 |
| 01:53 ET | 1691 | 0.5723 |
| 01:55 ET | 200 | 0.5717 |
| 01:57 ET | 100 | 0.5711 |
| 02:00 ET | 710 | 0.5743 |
| 02:02 ET | 100 | 0.5711 |
| 02:04 ET | 300 | 0.5711 |
| 02:06 ET | 1372 | 0.5732 |
| 02:08 ET | 100 | 0.5711 |
| 02:09 ET | 600 | 0.5732 |
| 02:11 ET | 700 | 0.5732 |
| 02:13 ET | 41787 | 0.57965 |
| 02:15 ET | 12454 | 0.58405 |
| 02:18 ET | 2210 | 0.5842 |
| 02:20 ET | 200 | 0.5843 |
| 02:22 ET | 400 | 0.5836 |
| 02:24 ET | 580 | 0.58415 |
| 02:26 ET | 59422 | 0.588 |
| 02:27 ET | 74172 | 0.5939 |
| 02:29 ET | 13553 | 0.5918 |
| 02:31 ET | 300 | 0.58895 |
| 02:33 ET | 200 | 0.589 |
| 02:36 ET | 900 | 0.5845 |
| 02:38 ET | 500 | 0.5845 |
| 02:40 ET | 1553 | 0.5864 |
| 02:42 ET | 300 | 0.5864 |
| 02:44 ET | 1129 | 0.5839 |
| 02:45 ET | 300 | 0.5815 |
| 02:47 ET | 2011 | 0.58165 |
| 02:49 ET | 400 | 0.58305 |
| 02:51 ET | 1200 | 0.5844 |
| 02:54 ET | 766 | 0.5844 |
| 02:56 ET | 230 | 0.5844 |
| 02:58 ET | 700 | 0.58445 |
| 03:00 ET | 2154 | 0.5845 |
| 03:02 ET | 2950 | 0.58445 |
| 03:03 ET | 3718 | 0.5874 |
| 03:05 ET | 1498 | 0.5875 |
| 03:07 ET | 29610 | 0.5817 |
| 03:09 ET | 100 | 0.5844 |
| 03:12 ET | 8542 | 0.584 |
| 03:14 ET | 875 | 0.584 |
| 03:16 ET | 265 | 0.584 |
| 03:18 ET | 1100 | 0.5853 |
| 03:20 ET | 1084 | 0.5813 |
| 03:21 ET | 1575 | 0.5873 |
| 03:23 ET | 1050 | 0.5873 |
| 03:25 ET | 2834 | 0.5823 |
| 03:27 ET | 1089 | 0.5823 |
| 03:30 ET | 968 | 0.5823 |
| 03:32 ET | 2634 | 0.5871 |
| 03:34 ET | 3754 | 0.587 |
| 03:36 ET | 9661 | 0.5868 |
| 03:38 ET | 3401 | 0.582744 |
| 03:39 ET | 42943 | 0.5909 |
| 03:41 ET | 6558 | 0.59 |
| 03:43 ET | 17686 | 0.5899 |
| 03:45 ET | 11478 | 0.5899 |
| 03:48 ET | 16177 | 0.589 |
| 03:50 ET | 5676 | 0.5891 |
| 03:52 ET | 34700 | 0.5921 |
| 03:54 ET | 32259 | 0.5936 |
| 03:56 ET | 54043 | 0.5828 |
| 03:57 ET | 2200 | 0.5862 |
| 03:59 ET | 5694 | 0.5828 |
May 15, 2024
DJ Sangamo Therapeutics Price Target Maintained With a $5.00/Share by HC Wainwright & Co., from 10:44AM ET on Wednesday May 15, 2024 by Dow Jones
10:44AM ET on Wednesday May 15, 2024 by Dow Jones
May 9, 2024
Sangamo Therapeutics Reports Recent Business Highlights and First Quarter 2024 Financial Results, from 4:01PM ET on Thursday May 09, 2024 by Dow Jones
4:01PM ET on Thursday May 09, 2024 by Dow Jones*DJ Sangamo Therapeutics 1Q EPS 0c >SGMO, from 4:01PM ET on Thursday May 09, 2024 by Dow Jones
4:01PM ET on Thursday May 09, 2024 by Dow JonesSangamo Therapeutics Presents Next-Generation Modular Integrase Technology Engineered to Enable Large-Scale Genome Editing, from 8:05AM ET on Thursday May 09, 2024 by Dow Jones
8:05AM ET on Thursday May 09, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Sangamo Therapeutics Inc | 117.1M | -0.3x | --- |
FibroGen Inc | 119.4M | -0.5x | --- |
Karyopharm Therapeutics Inc | 114.1M | -0.8x | --- |
Akebia Therapeutics Inc | 234.7M | -5.2x | --- |
Vanda Pharmaceuticals Inc | 297.4M | -60.5x | -37.98% |
Anika Therapeutics Inc | 380.3M | -5.1x | --- |
Company Information
Sangamo Therapeutics, Inc. is a genomic medicines company that is developing medicines for neurological diseases. The Company's neurology preclinical development is focused on two areas: development of epigenetic regulation therapies to treat serious neurological diseases, and development of novel engineered adeno-associated virus (AAV) capsids to deliver its therapies to the intended neurological targets. The Company's zinc finger epigenetic regulators are ideally suited to potentially address neurological disorders and its capsid discovery platform is expanding delivery beyond intrathecal delivery capsids, including in the central nervous system. Its clinical-stage product candidates are Isaralgagene civaparvovec, also known as ST-920, its wholly-owned gene therapy product candidate for the treatment of Fabry disease, and TX200, its wholly-owned CAR-Treg cell therapy product candidate for the prevention of immune-mediated rejection in HLA-A2 mismatched kidney transplantation.
Contact Information
- Headquarters
- 501 Canal Blvd.RICHMOND, CA, United States 94084
- Phone
- 510-970-6000
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- H. Stewart Parker
- President, Chief Executive Officer
- Alexander Macrae
- Chief Financial Officer, Senior Vice President
- Prathyusha Duraibabu
- Senior Vice President, General Counsel, Corporate Secretary
- Scott Willoughby
- Senior Vice President, Chief Development Officer
- Nathalie Dubois- Stringfellow
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $117.1M |
|---|---|
Revenue (TTM) | $18.8M |
Shares Outstanding | 207.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.35 |
EPS | $-1.86 |
Book Value | $0.47 |
P/E Ratio | -0.3x |
Price/Sales (TTM) | 6.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -1,831.76% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
